Our knowledge stewardship campaign is about universities managing access and ownership of knowledge and intellectual property in a way that focuses on equity and maximises global public benefit. UAEM aims to hold universities accountable on their missions to serve the public interests. In order to achieve that, UAEM students advocate universities to follow Global Access Licensing Principles (GAL) in their licensing agreements with pharmaceutical companies, to ensure that the end products are made affordable for people in middle and low income countries. Over the years, leading universities such as Harvard, Yale, Berkeley, University of British Columbia, Oxford, Bergen and others, included statements about global access in their licensing policies. Following UAEM`s efforts, in 2009 the “Statement of Principles and Strategies for the Equitable Dissemination of Medical Technologies” which was written by members of the “Association of University Technology Managers” (AUTM) and endorsed by many top research institutions as well as the NIH and CDC.
UAEM runs specific campaigns that target universities, such as the one to ensure that Johns Hopkins university makes new tuberculosis drug accessible globally.
To encourage more universities to live up to their social role, UAEM created a unique tool: The University Report Card which evaluates and compares top universities on their contributions to neglected biomedical research and access to medicines. In addition UAEM engages with national and regional institutions such as “ASTP Proton” (European technology transfer association) to create awareness and tools to advance knowledge stewardship by universities.